PMC:7019868 / 14129-14376 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"255","span":{"begin":14,"end":18},"obj":"Chemical"},{"id":"256","span":{"begin":99,"end":109},"obj":"Disease"},{"id":"257","span":{"begin":119,"end":126},"obj":"Disease"}],"attributes":[{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"MESH:D006973"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"esuspended in DPBS and then subjected to automated nucleic acid extraction using Cador Pathogen 96 QIAcube HT Kit with QIAcube (Qiagen Inc., Hilden, Germany) according to the manufacturer’s instructions. Complementary DNA was synthesized via rever"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T70","span":{"begin":218,"end":221},"obj":"Body_part"}],"attributes":[{"id":"A70","pred":"fma_id","subj":"T70","obj":"http://purl.org/sig/ont/fma/fma74412"}],"text":"esuspended in DPBS and then subjected to automated nucleic acid extraction using Cador Pathogen 96 QIAcube HT Kit with QIAcube (Qiagen Inc., Hilden, Germany) according to the manufacturer’s instructions. Complementary DNA was synthesized via rever"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T154","span":{"begin":107,"end":109},"obj":"http://purl.obolibrary.org/obo/CLO_0004265"}],"text":"esuspended in DPBS and then subjected to automated nucleic acid extraction using Cador Pathogen 96 QIAcube HT Kit with QIAcube (Qiagen Inc., Hilden, Germany) according to the manufacturer’s instructions. Complementary DNA was synthesized via rever"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T80","span":{"begin":51,"end":63},"obj":"Chemical"},{"id":"T81","span":{"begin":59,"end":63},"obj":"Chemical"},{"id":"T82","span":{"begin":218,"end":221},"obj":"Chemical"}],"attributes":[{"id":"A80","pred":"chebi_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A81","pred":"chebi_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_16991"}],"text":"esuspended in DPBS and then subjected to automated nucleic acid extraction using Cador Pathogen 96 QIAcube HT Kit with QIAcube (Qiagen Inc., Hilden, Germany) according to the manufacturer’s instructions. Complementary DNA was synthesized via rever"}